The tradeoff between the risks of acute rejection and new-onset diabetes after kidney transplant

American Journal of Kidney Diseases

Volumn 56, Issue 6, 2010, Pages 1026-1028

  Klein, Christina L ^a   Brennan, Daniel C ^a  

^a WASHINGTON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; MYCOPHENOLIC ACID; PREDNISOLONE; TACROLIMUS;

ACUTE GRAFT REJECTION; DEATH; DIABETES MELLITUS; DRUG APPROVAL; EDITORIAL; GLOMERULUS FILTRATION RATE; GRAFT FAILURE; GRAFT SURVIVAL; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; PROGNOSIS; RISK FACTOR;

CALCINEURIN; DIABETES MELLITUS; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY DISEASES; KIDNEY TRANSPLANTATION; PROGNOSIS; RISK ASSESSMENT; RISK FACTORS; STEROIDS;

EID: 78649406740     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ajkd.2010.09.010     Document Type: Editorial

References (12)

1. E.H. Cole, O. Johnston, C.L. Rose, and J.S. Gill Impact of acute rejection and new-onset diabetes on long-term transplant graft and patient survival Clin J Am Soc Nephrol 3 2008 814 821
2. A.J. Matas, K.J. Gillingham, and A. Humar Posttransplant diabetes mellitus and acute rejection: impact on kidney transplant outcome Transplantation 85 2008 338 343
3. F. Vincenti, S. Friman, and E. Scheuermann Results of an international, randomized trial comparing glucose metabolism disorders and outcome with cyclosporine versus tacrolimus Am J Transplant 7 2007 1506 1514
4. R.S. Woodward, M.A. Schnitzler, and J. Baty Incidence and cost of new onset diabetes mellitus among U.S. wait-listed and transplanted renal allograft recipients Am J Transplant 3 2003 590 598
5. F.G. Cosio, T.E. Pesavento, S. Kim, K. Osei, M. Henry, and R.M. Ferguson Patient survival after renal transplantation: IV. Impact of post-transplant diabetes Kidney Int 62 2002 1440 1446
6. J. Hjelmesaeth, A. Hartmann, and T. Leivestad The impact of early-diagnosed new-onset post-transplantation diabetes mellitus on survival and major cardiac events Kidney Int 69 2006 588 595
7. S. McDonald, G. Russ, S. Campbell, and S. Chadban Kidney transplant rejection in Australia and New Zealand: relationships between rejection and graft outcome Am J Transplant 7 2007 1201 1208
8. H.-T. Kuo, M.S. Sampaio, F. Vincenti, and S. Bunnapradist Associations of pretransplant diabetes mellitus, new-onset diabetes after transplant, and acute rejection with transplant outcomes: an analysis of the Organ Procurement and Transplant Network/United Network for Organ Sharing (OPTN/UNOS) Database Am J Kidney Dis 56 6 2010 1127 1139
9. OPTN/SRTR OPTN/SRTR annual report: immunosuppression use for maintenance prior to discharge, 1998 to 2007 recipients with kidney transplants http://www.ustransplant.org/annual-reports/current/506e-ki.htm Accessed August 27, 2010
10. H. Ekberg, H. Tedesco-Silva, and A. Demirbas Reduced exposure to calcineurin inhibitors in renal transplantation N Engl J Med 357 2007 2562 2575
11. E.S. Woodle, M.R. First, J. Pirsch, F. Shihab, A.O. Gaber, and P. Van Veldhuisen A prospective, randomized, double-blind, placebo-controlled multicenter trial comparing early (7 day) corticosteroid cessation versus long-term, low-dose corticosteroid therapy Ann Surg 248 2008 564 577
12. A. Durrbach, J.M. Pestana, and T. Pearson A phase III study of belatacept versus cyclosporine in kidney transplants from extended criteria donors (BENEFIT-EXT study) Am J Transplant 10 3 2010 547 557